24 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Tonix Pharmaceuticals, Inc. TNXP stock moved upwards by 65.7% to $0.67 during Wednesday's pre-market session.
• InflaRx, Inc. IFRX stock surged 15.8% to $4.84.
• Moderna, Inc. MRNA shares rose 11.3% to $26.44. The most recent rating by Bank of America, on December 03, is at Buy, with a price target of $29.00.
• Correvio Pharma, Inc. CORV shares increased by 11.1% to $0.40. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
• Guardion Health Sciences, Inc. GHSI shares moved upwards by 8.5% to $0.32.
• Alcon, Inc. ALC shares surged 7.9% to $63.45. The most recent rating by Morgan Stanley, on December 17, is at Overweight, with a price target of $70.00.
• Lipocine, Inc. LPCN stock surged 5.8% to $0.59.
• Amneal Pharmaceuticals, Inc. AMRX shares rose 5.0% to $5.00. The most recent rating by RBC Capital, on January 02, is at Sector Perform, with a price target of $4.00.
• Endo International, Inc. ENDP stock surged 4.9% to $6.85. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $7.00.
• Mallinckrodt, Inc. MNK shares moved upwards by 4.2% to $4.95.
• ProQR Therapeutics, Inc. PRQR stock rose 3.6% to $8.00.
• Novavax, Inc. NVAX stock moved upwards by 3.1% to $8.20.
• Genprex, Inc. GNPX shares moved upwards by 2.7% to $6.40.
• Gilead Sciences, Inc. GILD stock surged 2.3% to $71.70. The most recent rating by Bernstein, on February 06, is at Market Perform, with a price target of $70.00.
• OPKO Health, Inc. OPK shares surged 2.2% to $1.42.
• Innate Pharma, Inc. IPHA shares rose 2.0% to $7.23.

Losers

• SmileDirectClub, Inc. SDC stock plummeted 22.8% to $8.75 during Wednesday's pre-market session. The most recent rating by Wolfe Research, on January 09, is at Underperform, with a price target of $7.00.
• Spherix, Inc. SPEX stock fell 22.1% to $1.90.
• Cocrystal Pharma, Inc. COCP stock fell 8.2% to $2.01.
• TG Therapeutics, Inc. TGTX shares declined 5.8% to $13.35. The most recent rating by H.C. Wainwright, on January 17, is at Buy, with a price target of $24.00.
• Titan Pharmaceuticals, Inc. TTNP stock decreased by 4.5% to $0.21.
• Advaxis, Inc. ADXS shares decreased by 3.7% to $0.84.
• Catabasis Pharmaceuticals, Inc. CATB shares plummeted 3.5% to $4.70.
• Heat Biologics, Inc. HTBX shares decreased by 3.3% to $0.23. The most recent rating by Maxim Group, on February 06, is at Buy, with a price target of $1.00.